MEDS Mask Stock: Getting to Know the Business of the Medical Equipment Issuer and Its Products

Volcanic ash from Anak Krakatau spreading to various regions turned out to have an unexpected side effect on the stock exchange. MEDS stock, a medical equipment issuer that has rarely been in the spotlight, suddenly surged to hit the Upper Auto Reject (ARA) on 7 September 2026. 

The trigger was simple: mask demand shot up dramatically as people needed respiratory protection from volcanic ash exposure.

Key Takeaways

• MEDS stock jumped 34.72% to Rp97 on 7 September 2026, driven by high demand for masks due to the eruption of Mount Anak Krakatau.
• PT Hetzer Medical Indonesia Tbk produces masks, surgical caps, stethoscopes, and sphygmomanometers under the Evo Plusmed brand, which were once used by the Indonesian contingent at international events.
• Despite the stock price surge, the company's EBITDA is still negative and it has never paid dividends, indicating long‑term profitability challenges.

Business Profile and Products of PT Hetzer Medical Indonesia Tbk

MEDS stock is the ticker symbol of PT Hetzer Medical Indonesia Tbk, a health‑sector issuer operating in the medical equipment industry and its derivatives. 

According to the company’s 2024 annual report, Hetzer Medical Indonesia was founded in 2010 and a year later began producing surgical masks. The company became the first manufacturer to produce 4‑dimension earloop medical masks in Indonesia, an innovation that set it apart from similar competitors.

The company’s product line has expanded over time. In 2018, it started producing surgical caps, or bouffant caps. 

Read Also: Nvidia’s $500 Billion AI Funding, Will AI Crypto Tokens Also Benefit?

Only starting in 2023 did Hetzer Medical Indonesia expand its product types to include stethoscopes and sphygmomanometers. All these medical devices are marketed under the Evo Plusmed brand and are produced in two factories located in Cimahi, West Java.

Interestingly, the Evo Plusmed brand has a rather impressive track record. Their mask products were used by the Indonesian contingent at the Tokyo 2020 Olympics, PON Papua 2021, and even the Pertamina Mandalika MotoGP 2022, according to a report from Sumbarbisnis.com. 

In addition, during the pandemic, the company was also involved in efforts to reduce the shortage of medical masks for the public by providing support to the government through BIN and BNPB.

Read Also: BIS Reveals New Potential of XRP Ledger for Digital Financial Systems

Ownership Structure and IPO History of MEDS Stock

Source: IDX

Hetzer Medical Indonesia listed its shares on the exchange in 2022 and is listed on the development board. At the IPO, the company released 312.5 million shares, equivalent to 20% of its paid‑up capital, at an offering price of Rp125 per share, raising Rp39.06 billion.

Regarding ownership structure, based on the monthly report of securities holder registration as of 31 October 2025, the controlling shareholder of MEDS is Jemmy Kurniawan, with ownership of 1.04 billion shares, equivalent to 67.04%. 

Read Also: 9 Advantages of Profitable Digital Gold Investment in 2026 (XAUT & PAXG)

The next major shareholder is Fancy Marsiana with 3.64%, while the public holds the remaining 29.08%. Jemmy Kurniawan himself currently serves as the company’s chief commissioner.

If you are interested in tracking the movement of high‑volatility assets like this small‑cap stock and want to start exploring diversification into digital assets, you can directly  register on Bittime to start trading crypto easily and securely.

Catalysts Behind the Price Surge and Current Fundamental Conditions

The surge in MEDS stock on 7 September 2026 was not without reason. According to a Sumbar Bisnis report, the stock of this medical equipment issuer jumped 34.72% to Rp97 per share in the first trading session, driven by high market demand for medical masks due to the impact of the Mount Anak Krakatau eruption spreading to various regions. 

Technical data from Investing.com on the same day showed a "Strong Buy" summary, with 12 out of 12 moving average signals and 6 out of 6 technical indicators showing buy trends, although the RSI had reached 86, indicating extreme overbought conditions.

From a fundamental perspective, the company's financial performance shows positive growth trends in the current year. As of the first half of 2026, MEDS’s cumulative revenue reached Rp11.53 billion, driven by increased demand volumes for masks from both new and old distributors. 

Read Also: 9 Advantages of Profitable Digital Gold Investment in 2026 (XAUT & PAXG)

The company has also started expanding its business into metal fabrication services, targeting the manufacturing and automotive markets as a form of diversification beyond its core medical equipment business.

That said, it is important to note that MEDS is still a small‑scale issuer with structural profitability challenges. The company's EBITDA is negative at Rp307.06 billion with an EBITDA margin of -60.36%, it has only 16 employees, and it has never paid dividends to its shareholders. 

Its market capitalisation ranges from Rp112.5–153 billion depending on the measurement time, placing MEDS as a small‑cap stock that naturally has very high price volatility.

Read Also: Futures Trading for Beginners: How It Works, Tips, and Risks

Conclusion

MEDS stock is an interesting example of how a small issuer in the medical equipment sector can suddenly become a market darling when an environmental emergency—in this case, volcanic ash from Anak Krakatau—suddenly boosts demand for its core products. 

Behind this sharp price surge, Hetzer Medical Indonesia actually has a fairly solid business foundation through the track record of its Evo Plusmed products at various national and international events, although profitability challenges still loom with negative EBITDA. 

Monitor US stock tokens: AMZON, AMDON, TSLAX, NFLXON MSFTON and many more—you can start trading on Bittime.

Bittime is a Digital Financial Asset Trader (PAKD) platform licensed and supervised by the Financial Services Authority — where you can  buy Bitcoin in Indonesia and hundreds of other crypto assets starting from Rp10,000. Registration is fast, secure, and can be started today.

Monitor  USDT to IDR conversion and real‑time price movements of your favourite crypto assets. All available in one  crypto investment app that can be downloaded for free from the Play Store.

Ready to start? Register now on Bittime and execute your investment strategy with a platform trusted by millions of users in Indonesia.

FAQ

What is the main business of PT Hetzer Medical Indonesia Tbk (MEDS)? 

The company operates in the medical equipment industry, producing masks, surgical caps, stethoscopes, and sphygmomanometers under the Evo Plusmed brand. Its production is supported by two factories located in Cimahi, West Java.

Why did MEDS stock surge sharply on 7 September 2026? 

The surge was triggered by high market demand for medical masks due to the impact of the Mount Anak Krakatau eruption spreading to various regions. The stock even hit the Upper Auto Reject (ARA) in the first trading session.

Who currently controls MEDS shares? 

The controlling shareholder of MEDS is Jemmy Kurniawan, with ownership of 67.04% of the total registered shares. He also serves as the chief commissioner of the company.

Does MEDS stock pay dividends to its shareholders? 

No, MEDS has never paid dividends to its shareholders. This is in line with the company’s still‑negative EBITDA.

Is the surge in MEDS stock long‑term or temporary? 

This surge is more of a short‑term sentiment play driven by an environmental emergency that suddenly boosted mask demand. The company’s profitability fundamentals, such as its still‑negative EBITDA, have not changed significantly from this temporary demand spike.